PUBLISHER: IMARC | PRODUCT CODE: 1519525
PUBLISHER: IMARC | PRODUCT CODE: 1519525
Equine Healthcare Market by Product, Indication, Distribution Channel, and Region 2024-2032
The global equine healthcare market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The rapid increase in the equine population, rising awareness among owners regarding equine health and proper nutrition, and the utilization of advanced imaging techniques represent some of the key factors driving the market.
Equine healthcare is a branch of veterinary medicine that focuses on the diagnosis, treatment, and prevention of diseases in horses. It involves the utilization of various products, such as vaccines, dewormers, topical treatments, joint supplements, prebiotics, fly sprays, hoof conditioners, antiseptics, and performance additives. Equine healthcare includes preventive care, illness management, lameness treatment, reproductive care, oral hygiene, rehabilitation, and addressing behavioral issues. It assists in improving overall health, preventing future complications, allowing early disease detection, facilitating successful breeding, promoting a longer lifespan, and reducing the risk of serious diseases, such as lameness, dental problems, infections, obesity, herpes, and rabies.
Equine Healthcare Market Trends:
The rapid increase in the equine population due to the widespread utilization of horses in racing, farming, and as companions is one of the primary factors propelling the market growth. Equine healthcare services and products, such as preventive care, reproductive services, rehabilitation centers, vaccines, and health supplements, are widely used to ensure optimum performance, prevent complications, protect from injuries, and reduce the risk of illnesses. In addition to this, rising awareness among the owners regarding the importance of equine health and proper nutrition is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to support animal welfare, promote responsible ownership, and provide access to high-quality healthcare facilities is positively influencing the market growth. Additionally, the utilization of advanced imaging techniques, such as digital radiography, ultrasound, and endoscopy, to provide detailed cross-sectional images of the horse's body, thus allowing the diagnosis of musculoskeletal injuries, lameness, and internal diseases, is contributing to the market growth. Besides this, the recent development of wearable health monitoring devices for horses, which allows continuous monitoring of vital signs, activity levels, and behavior to facilitate early detection of any health issues, is providing an impetus to the market growth. Moreover, the growing number of equine sports, such as racing, jumping, dressage, and endurance riding, is propelling the market growth. Other factors, including rising expenditure capacities of consumers, emerging trends of pet humanization, extensive research and development (R&D) activities, and rapid expansion of the e-commerce industry, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global equine healthcare market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, indication, and distribution channel.
Product Insights:
Drugs
Anti-Inflammatory Drugs
Parasiticide Drugs
Others
Vaccines
Live Attenuated Vaccine
Recombinant Vaccine
Others
Medicated Feed Additives
Diagnostics
Others
The report has provided a detailed breakup and analysis of the equine healthcare market based on the product. This includes drugs (anti-inflammatory drugs, parasiticide drugs, and others), vaccines (live attenuated vaccine, recombinant vaccine, and others), medicated feed additives, diagnostics, and others. According to the report, drugs represented the largest segment.
Indication Insights:
Musculoskeletal Disorders
Parasite Control
Equine Herpes Virus
Equine Encephalomyelitis
Equine Influenza
West Nile Virus
Tetanus
Rabies
Others
A detailed breakup and analysis of the equine healthcare market based on the indication has also been provided in the report. This includes musculoskeletal disorders, parasite control, equine herpes virus, equine encephalomyelitis, equine influenza, West Nile virus, tetanus, rabies, and others. According to the report, parasite control accounted for the largest market share.
Distribution Channel Insights:
Veterinary Hospitals and Clinics
Retail Pharmacies and Drug Stores
A detailed breakup and analysis of the equine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals and clinics and retail pharmacies and drug stores. According to the report, veterinary hospitals and clinics accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for equine healthcare. Some of the factors driving the North America equine healthcare market included the rising equine population, supportive government policies, and significant technological advancements.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global equine healthcare market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Esaote SpA, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global equine healthcare market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global equine healthcare market?
- What is the impact of each driver, restraint, and opportunity on the global equine healthcare market?
- What are the key regional markets?
- Which countries represent the most attractive equine healthcare market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the equine healthcare market?
- What is the breakup of the market based on the indication?
- Which is the most attractive indication in the equine healthcare market?
- What is the breakup of the market based on distribution channel?
- Which is the most attractive distribution channel in the equine healthcare market?
- What is the competitive structure of the global equine healthcare market?
- Who are the key players/companies in the global equine healthcare market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Equine Healthcare Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Drugs
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Anti-Inflammatory Drugs
- 6.1.2.2 Parasiticide Drugs
- 6.1.2.3 Others
- 6.1.3 Market Forecast
- 6.2 Vaccines
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Live Attenuated Vaccine
- 6.2.2.2 Recombinant Vaccine
- 6.2.2.3 Others
- 6.2.3 Market Forecast
- 6.3 Medicated Feed Additives
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Diagnostics
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Indication
- 7.1 Musculoskeletal Disorders
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Parasite Control
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Equine Herpes Virus
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Equine Encephalomyelitis
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Equine Influenza
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 West Nile Virus
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Tetanus
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
- 7.8 Rabies
- 7.8.1 Market Trends
- 7.8.2 Market Forecast
- 7.9 Others
- 7.9.1 Market Trends
- 7.9.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Veterinary Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacies and Drug Stores
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Boehringer Ingelheim International GmbH
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 SWOT Analysis
- 14.3.2 Ceva
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 SWOT Analysis
- 14.3.3 Dechra Pharmaceuticals PLC
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Elanco Animal Health Incorporated
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Esaote SpA
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 SWOT Analysis
- 14.3.6 Hallmarq Veterinary Imaging
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 SWOT Analysis
- 14.3.7 IDEXX Laboratories Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Merck & Co. Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Vetoquinol S.A.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Zoetis Inc
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Boehringer Ingelheim International GmbH
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Equine Healthcare Market: Major Drivers and Challenges
- Figure 2: Global: Equine Healthcare Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Equine Healthcare Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Equine Healthcare Market: Breakup by Product (in %), 2023
- Figure 5: Global: Equine Healthcare Market: Breakup by Indication (in %), 2023
- Figure 6: Global: Equine Healthcare Market: Breakup by Distribution Channel (in %), 2023
- Figure 7: Global: Equine Healthcare Market: Breakup by Region (in %), 2023
- Figure 8: Global: Equine Healthcare (Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Equine Healthcare (Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Equine Healthcare (Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Equine Healthcare (Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Equine Healthcare (Medicated Feed Additives) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Equine Healthcare (Medicated Feed Additives) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Equine Healthcare (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Equine Healthcare (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Equine Healthcare (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Equine Healthcare (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Equine Healthcare (Musculoskeletal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Equine Healthcare (Musculoskeletal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Equine Healthcare (Parasite Control) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Equine Healthcare (Parasite Control) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Equine Healthcare (Equine Herpes Virus) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Equine Healthcare (Equine Herpes Virus) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Equine Healthcare (Equine Encephalomyelitis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Equine Healthcare (Equine Encephalomyelitis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Equine Healthcare (Equine Influenza) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Equine Healthcare (Equine Influenza) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Equine Healthcare (West Nile Virus) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Equine Healthcare (West Nile Virus) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Equine Healthcare (Tetanus) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Equine Healthcare (Tetanus) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Global: Equine Healthcare (Rabies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Global: Equine Healthcare (Rabies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Global: Equine Healthcare (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Global: Equine Healthcare (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: North America: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: North America: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: United States: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: United States: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Canada: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Canada: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Asia-Pacific: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Asia-Pacific: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: China: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: China: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Japan: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Japan: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: India: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: India: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: South Korea: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: South Korea: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Australia: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Australia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Indonesia: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Indonesia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Others: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Europe: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Europe: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Germany: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Germany: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: France: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: France: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: United Kingdom: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: United Kingdom: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Italy: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Italy: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Spain: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Spain: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Russia: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Russia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Others: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Latin America: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Latin America: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Brazil: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 81: Brazil: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 82: Mexico: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 83: Mexico: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 84: Others: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 85: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 86: Middle East and Africa: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
- Figure 87: Middle East and Africa: Equine Healthcare Market: Breakup by Country (in %), 2023
- Figure 88: Middle East and Africa: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 89: Global: Equine Healthcare Industry: Drivers, Restraints, and Opportunities
- Figure 90: Global: Equine Healthcare Industry: Value Chain Analysis
- Figure 91: Global: Equine Healthcare Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Equine Healthcare Market: Key Industry Highlights, 2023 & 2032
- Table 2: Global: Equine Healthcare Market Forecast: Breakup by Product (in Million US$), 2024-2032
- Table 3: Global: Equine Healthcare Market Forecast: Breakup by Indication (in Million US$), 2024-2032
- Table 4: Global: Equine Healthcare Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
- Table 5: Global: Equine Healthcare Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Equine Healthcare Market: Competitive Structure
- Table 7: Global: Equine Healthcare Market: Key Players
